Global Bioprocess Validation Market – Forecast and Analysis (2019-2026), by Test Type, Process Component, End-User and Region.

Market Scenario

Global Bioprocess Validation Market was valued at USD xx billion in 2019 and is expected to reach at USD xx billion by 2026 at a CAGR of xx% during forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Market Drivers and Restrains: Global Bioprocess Validation Market are driven by Stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries, high demand for the outsourcing of Bioprocess Validation Market services, and regulatory mandates in the healthcare industry to maintain compliance with good manufacturing practices. Additionally, increasing awareness about the advantages of biopharmaceutical drugs, and the growing number of CROs & CDMOs, the favourable government initiatives to promote the growth of the pharmaceutical and biotechnology industries in several countries such factors are propel the market growth during forecast period. Global Bioprocess Validation Market Regional Analysis: Geographically, Global Bioprocess Validation Market is segmented into APAC, North America, Europe, and MEA & Africa. APAC is anticipated to exhibit largest market share of xx% CAGR during forecast period. The increasing number of biopharmaceutical manufacturing capabilities in Asian countries, increasing demand for outsourcing Bioprocess Validation Market , growing life science research and development specific by pharmaceutical and biotechnology companies is expected to drive market growth in APAC. Global Bioprocess Validation Market Segment Analysis: Based on End Users End-User Global Bioprocess Validation Market is segmented into CDMO, Biotechnology and Pharmaceutical Companies. Pharmaceutical companies are expected to be the largest end users of Bioprocess Validation Market during forecast period. The large share of this segment can majorly be attributed to increasing production of biopharmaceuticals and the corresponding increase in the number of impurities to be checked for, the stringency of standards and regulations regarding the quality and validity of bioprocesses involved in the production. Global Bioprocess Validation Market 11

Scope of Report:

Global Bioprocess Validation Market by Test Type

• Extractables and Leachables • Integrity Testing • Microbiology Testing

Global Bioprocess Validation Market by Process Component

• Filter Element • Bioreactors

Global Bioprocess Validation Market by End-User

• CDMO • Biotechnology • Pharmaceutical

Global Bioprocess Validation Market by Region:

• APAC • North America • Europe • MEA& Africa

Global Bioprocess Validation Market Major Players:

• Merck KGaA (Germany) • SGS S.A. (Switzerland) • Eurofins Scientific (Luxembourg) • Sartorius Stedim Biotech (France) • Pall Corporation (US) • Cobetter Filtration Equipments Co., Ltd. (China) • Toxikon Corporation (US) • DOC S.r.l. (Italy) • MEISSNER FILTRATION PRODUCTS, INC. (US) • Thermo Fisher Scientific (US)

Table of Contents

Global Bioprocess Validation Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.2. Secondary data 2.3.3. Secondary Sources 2.3.4. Primary Research 2.3.5. Data from Primary Sources 2.3.6. Breakdown of Primary Sources 3. Executive Summary: Global Bioprocess Validation Market , by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends in Global Bioprocess Validation Market and Emerging Technologies 4.8. Global Bioprocess Validation Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Bioprocess Validation Market Analysis and Forecast 6.1. Global Bioprocess Validation Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Bioprocess Validation Market Analysis and Forecast, By Test Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Bioprocess Validation Market Value Share Analysis, By Test Type 7.4. Global Bioprocess Validation Market Size (US$ Bn) Forecast, By Test Type 7.5. Global Bioprocess Validation Market Analysis, By Test Type 7.6. Global Bioprocess Validation Market Attractiveness Analysis, By Test Type 8. Global Bioprocess Validation Market Analysis and Forecast, By Process Component 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Bioprocess Validation Market Value Share Analysis, By Process Component 8.4. Global Bioprocess Validation Market Size (US$ Bn) Forecast, By Process Component 8.5. Global Bioprocess Validation Market Analysis, By Process Component 8.6. Global Bioprocess Validation Market Attractiveness Analysis, By Process Component 9. Global Bioprocess Validation Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Bioprocess Validation Market Value Share Analysis, by End User 9.4. Global Bioprocess Validation Market Size (US$ Bn) Forecast, by End User 9.5. Global Bioprocess Validation Market Analysis, by End User 9.6. Global Bioprocess Validation Market Attractiveness Analysis, by End User 10. Global Bioprocess Validation Market Analysis, by Region 10.1. Global Bioprocess Validation Market Value Share Analysis, by Region 10.2. Global Bioprocess Validation Market Size (US$ Bn) Forecast, by Region 10.3. Global Bioprocess Validation Market Attractiveness Analysis, by Region 11. North America Bioprocess Validation Market Analysis 11.1. Key Findings 11.2. North America Bioprocess Validation Market Overview 11.3. North America Bioprocess Validation Market Value Share Analysis, By Test Type 11.4. North America Bioprocess Validation Market Forecast, By Test Type 11.4.1. Extractables and Leachables 11.4.2. Integrity Testing 11.4.3. Microbiology Testing 11.5. North America Bioprocess Validation Market Value Share Analysis, By Process Component 11.6. North America Bioprocess Validation Market Forecast, By Process Component 11.6.1. Filter Element 11.6.2. Bioreactors 11.7. North America Bioprocess Validation Market Value Share Analysis, by End User 11.8. North America Bioprocess Validation Market Forecast, by End User 11.8.1. CDMO 11.8.2. Biotechnology 11.8.3. Pharmaceutical 11.9. North America Bioprocess Validation Market Value Share Analysis, by Country 11.10. North America Bioprocess Validation Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Bioprocess Validation Market Analysis, by Country 11.12. U.S. Bioprocess Validation Market Forecast, By Test Type 11.12.1. Extractables and Leachables 11.12.2. Integrity Testing 11.12.3. Microbiology Testing 11.13. U.S. Bioprocess Validation Market Forecast, By Process Component 11.13.1. Filter Element 11.13.2. Bioreactors 11.14. U.S. Bioprocess Validation Market Forecast, by End User 11.14.1. CDMO 11.14.2. Biotechnology 11.14.3. Pharmaceutical 11.15. Canada Bioprocess Validation Market Forecast, By Test Type 11.15.1. Extractables and Leachables 11.15.2. Integrity Testing 11.15.3. Microbiology Testing 11.16. Canada Bioprocess Validation Market Forecast, By Process Component 11.16.1. Filter Element 11.16.2. Bioreactors 11.17. Canada Bioprocess Validation Market Forecast, by End User 11.17.1. CDMO 11.17.2. Biotechnology 11.17.3. Pharmaceutical 11.18. North America Bioprocess Validation Market Attractiveness Analysis 11.18.1. By Test Type 11.18.2. By Process Component 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Bioprocess Validation Market Analysis 12.1. Key Findings 12.2. Europe Bioprocess Validation Market Overview 12.3. Europe Bioprocess Validation Market Value Share Analysis, By Test Type 12.4. Europe Bioprocess Validation Market Forecast, By Test Type 12.4.1. Extractables and Leachables 12.4.2. Integrity Testing 12.4.3. Microbiology Testing 12.5. Europe Bioprocess Validation Market Value Share Analysis, By Process Component 12.6. Europe Bioprocess Validation Market Forecast, By Process Component 12.6.1. Filter Element 12.6.2. Bioreactors 12.7. Europe Bioprocess Validation Market Value Share Analysis, by End User 12.8. Europe Bioprocess Validation Market Forecast, by End User 12.8.1. CDMO 12.8.2. Biotechnology 12.8.3. Pharmaceutical 12.9. Europe Bioprocess Validation Market Value Share Analysis, by Country 12.10. Europe Bioprocess Validation Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Bioprocess Validation Market Analysis, by Country 12.12. Germany Bioprocess Validation Market Forecast, By Test Type 12.12.1. Extractables and Leachables 12.12.2. Integrity Testing 12.12.3. Microbiology Testing 12.13. Germany Bioprocess Validation Market Forecast, By Process Component 12.13.1. Filter Element 12.13.2. Bioreactors 12.14. Germany Bioprocess Validation Market Forecast, by End User 12.14.1. CDMO 12.14.2. Biotechnology 12.14.3. Pharmaceutical 12.15. U.K. Bioprocess Validation Market Forecast, By Test Type 12.15.1. Extractables and Leachables 12.15.2. Integrity Testing 12.15.3. Microbiology Testing 12.16. U.K. Bioprocess Validation Market Forecast, By Process Component 12.16.1. Filter Element 12.16.2. Bioreactors 12.17. U.K. Bioprocess Validation Market Forecast, by End User 12.17.1. CDMO 12.17.2. Biotechnology 12.17.3. Pharmaceutical 12.18. France Bioprocess Validation Market Forecast, By Test Type 12.18.1. Extractables and Leachables 12.18.2. Integrity Testing 12.18.3. Microbiology Testing 12.19. France Bioprocess Validation Market Forecast, By Process Component 12.19.1. Filter Element 12.19.2. Bioreactors 12.20. France Bioprocess Validation Market Forecast, by End User 12.20.1. CDMO 12.20.2. Biotechnology 12.20.3. Pharmaceutical 12.21. Italy Bioprocess Validation Market Forecast, By Test Type 12.21.1. Extractables and Leachables 12.21.2. Integrity Testing 12.21.3. Microbiology Testing 12.22. Italy Bioprocess Validation Market Forecast, By Process Component 12.22.1. Filter Element 12.22.2. Bioreactors 12.23. Italy Bioprocess Validation Market Forecast, by End User 12.23.1. CDMO 12.23.2. Biotechnology 12.23.3. Pharmaceutical 12.24. Spain Bioprocess Validation Market Forecast, By Test Type 12.24.1. Extractables and Leachables 12.24.2. Integrity Testing 12.24.3. Microbiology Testing 12.25. Spain Bioprocess Validation Market Forecast, By Process Component 12.25.1. Filter Element 12.25.2. Bioreactors 12.26. Spain Bioprocess Validation Market Forecast, by End User 12.26.1. CDMO 12.26.2. Biotechnology 12.26.3. Pharmaceutical 12.27. Rest of Europe Bioprocess Validation Market Forecast, By Test Type 12.27.1. Extractables and Leachables 12.27.2. Integrity Testing 12.27.3. Microbiology Testing 12.28. Rest of Europe Bioprocess Validation Market Forecast, By Process Component 12.28.1. Filter Element 12.28.2. Bioreactors 12.29. Rest of Europe Bioprocess Validation Market Forecast, by End User 12.29.1. CDMO 12.29.2. Biotechnology 12.29.3. Pharmaceutical 12.30. Europe Bioprocess Validation Market Attractiveness Analysis 12.30.1. By Test Type 12.30.2. By Process Component 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Bioprocess Validation Market Analysis 13.1. Key Findings 13.2. Asia Pacific Bioprocess Validation Market Overview 13.3. Asia Pacific Bioprocess Validation Market Value Share Analysis, By Test Type 13.4. Asia Pacific Bioprocess Validation Market Forecast, By Test Type 13.4.1. Extractables and Leachables 13.4.2. Integrity Testing 13.4.3. Microbiology Testing 13.5. Asia Pacific Bioprocess Validation Market Value Share Analysis, By Process Component 13.6. Asia Pacific Bioprocess Validation Market Forecast, By Process Component 13.6.1. Filter Element 13.6.2. Bioreactors 13.7. Asia Pacific Bioprocess Validation Market Value Share Analysis, by End User 13.8. Asia Pacific Bioprocess Validation Market Forecast, by End User 13.8.1. CDMO 13.8.2. Biotechnology 13.8.3. Pharmaceutical 13.9. Asia Pacific Bioprocess Validation Market Value Share Analysis, by Country 13.10. Asia Pacific Bioprocess Validation Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Bioprocess Validation Market Analysis, by Country 13.12. China Bioprocess Validation Market Forecast, By Test Type 13.12.1. Extractables and Leachables 13.12.2. Integrity Testing 13.12.3. Microbiology Testing 13.13. China Bioprocess Validation Market Forecast, By Process Component 13.13.1. Filter Element 13.13.2. Bioreactors 13.14. China Bioprocess Validation Market Forecast, by End User 13.14.1. CDMO 13.14.2. Biotechnology 13.14.3. Pharmaceutical 13.15. India Bioprocess Validation Market Forecast, By Test Type 13.15.1. Extractables and Leachables 13.15.2. Integrity Testing 13.15.3. Microbiology Testing 13.16. India Bioprocess Validation Market Forecast, By Process Component 13.16.1. Filter Element 13.16.2. Bioreactors 13.17. India Bioprocess Validation Market Forecast, by End User 13.17.1. CDMO 13.17.2. Biotechnology 13.17.3. Pharmaceutical 13.18. Japan Bioprocess Validation Market Forecast, By Test Type 13.18.1. Extractables and Leachables 13.18.2. Integrity Testing 13.18.3. Microbiology Testing 13.19. Japan Bioprocess Validation Market Forecast, By Process Component 13.19.1. Filter Element 13.19.2. Bioreactors 13.20. Japan Bioprocess Validation Market Forecast, by End User 13.20.1. CDMO 13.20.2. Biotechnology 13.20.3. Pharmaceutical 13.21. ASEAN Bioprocess Validation Market Forecast, By Test Type 13.21.1. Extractables and Leachables 13.21.2. Integrity Testing 13.21.3. Microbiology Testing 13.22. ASEAN Bioprocess Validation Market Forecast, By Process Component 13.22.1. Filter Element 13.22.2. Bioreactors 13.23. ASEAN Bioprocess Validation Market Forecast, by End User 13.23.1. CDMO 13.23.2. Biotechnology 13.23.3. Pharmaceutical 13.24. Rest of Asia Pacific Bioprocess Validation Market Forecast, By Test Type 13.24.1. Extractables and Leachables 13.24.2. Integrity Testing 13.24.3. Microbiology Testing 13.25. Rest of Asia Pacific Bioprocess Validation Market Forecast, By Process Component 13.25.1. Filter Element 13.25.2. Bioreactors 13.26. Rest of Asia Pacific Bioprocess Validation Market Forecast, by End User 13.26.1. CDMO 13.26.2. Biotechnology 13.26.3. Pharmaceutical 13.27. Asia Pacific Bioprocess Validation Market Attractiveness Analysis 13.27.1. By Test Type 13.27.2. By Process Component 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Bioprocess Validation Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Bioprocess Validation Market Overview 14.3. Middle East & Africa Bioprocess Validation Market Value Share Analysis, By Test Type 14.4. Middle East & Africa Bioprocess Validation Market Forecast, By Test Type 14.4.1. Extractables and Leachables 14.4.2. Integrity Testing 14.4.3. Microbiology Testing 14.5. Middle East & Africa Bioprocess Validation Market Value Share Analysis, By Process Component 14.6. Middle East & Africa Bioprocess Validation Market Forecast, By Process Component 14.6.1. Filter Element 14.6.2. Bioreactors 14.7. Middle East & Africa Bioprocess Validation Market Value Share Analysis, by End User 14.8. Middle East & Africa Bioprocess Validation Market Forecast, by End User 14.8.1. CDMO 14.8.2. Biotechnology 14.8.3. Pharmaceutical 14.9. Middle East & Africa Bioprocess Validation Market Value Share Analysis, by Country 14.10. Middle East & Africa Bioprocess Validation Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Bioprocess Validation Market Analysis, by Country 14.12. GCC Bioprocess Validation Market Forecast, By Test Type 14.12.1. Extractables and Leachables 14.12.2. Integrity Testing 14.12.3. Microbiology Testing 14.13. GCC Bioprocess Validation Market Forecast, By Process Component 14.13.1. Filter Element 14.13.2. Bioreactors 14.14. GCC Bioprocess Validation Market Forecast, by End User 14.14.1. CDMO 14.14.2. Biotechnology 14.14.3. Pharmaceutical 14.15. South Africa Bioprocess Validation Market Forecast, By Test Type 14.15.1. Extractables and Leachables 14.15.2. Integrity Testing 14.15.3. Microbiology Testing 14.16. South Africa Bioprocess Validation Market Forecast, By Process Component 14.16.1. Filter Element 14.16.2. Bioreactors 14.17. South Africa Bioprocess Validation Market Forecast, by End User 14.17.1. CDMO 14.17.2. Biotechnology 14.17.3. Pharmaceutical 14.18. Rest of Middle East & Africa Bioprocess Validation Market Forecast, By Test Type 14.18.1. Extractables and Leachables 14.18.2. Integrity Testing 14.18.3. Microbiology Testing 14.19. Rest of Middle East & Africa Bioprocess Validation Market Forecast, By Process Component 14.19.1. Filter Element 14.19.2. Bioreactors 14.20. Rest of Middle East & Africa Bioprocess Validation Market Forecast, by End User 14.20.1. CDMO 14.20.2. Biotechnology 14.20.3. Pharmaceutical 14.21. Middle East & Africa Bioprocess Validation Market Attractiveness Analysis 14.21.1. By Test Type 14.21.2. By Process Component 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Bioprocess Validation Market Analysis 15.1. Key Findings 15.2. South America Bioprocess Validation Market Overview 15.3. South America Bioprocess Validation Market Value Share Analysis, By Test Type 15.4. South America Bioprocess Validation Market Forecast, By Test Type 15.4.1. Extractables and Leachables 15.4.2. Integrity Testing 15.4.3. Microbiology Testing 15.5. South America Bioprocess Validation Market Value Share Analysis, By Process Component 15.6. South America Bioprocess Validation Market Forecast, By Process Component 15.6.1. Filter Element 15.6.2. Bioreactors 15.7. South America Bioprocess Validation Market Value Share Analysis, by End User 15.8. South America Bioprocess Validation Market Forecast, by End User 15.8.1. CDMO 15.8.2. Biotechnology 15.8.3. Pharmaceutical 15.9. South America Bioprocess Validation Market Value Share Analysis, by Country 15.10. South America Bioprocess Validation Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Bioprocess Validation Market Analysis, by Country 15.12. Brazil Bioprocess Validation Market Forecast, By Test Type 15.12.1. Extractables and Leachables 15.12.2. Integrity Testing 15.12.3. Microbiology Testing 15.13. Brazil Bioprocess Validation Market Forecast, By Process Component 15.13.1. Filter Element 15.13.2. Bioreactors 15.14. Brazil Bioprocess Validation Market Forecast, by End User 15.14.1. CDMO 15.14.2. Biotechnology 15.14.3. Pharmaceutical 15.15. Mexico Bioprocess Validation Market Forecast, By Test Type 15.15.1. Extractables and Leachables 15.15.2. Integrity Testing 15.15.3. Microbiology Testing 15.16. Mexico Bioprocess Validation Market Forecast, By Process Component 15.16.1. Filter Element 15.16.2. Bioreactors 15.17. Mexico Bioprocess Validation Market Forecast, by End User 15.17.1. CDMO 15.17.2. Biotechnology 15.17.3. Pharmaceutical 15.18. Rest of South America Bioprocess Validation Market Forecast, By Test Type 15.18.1. Extractables and Leachables 15.18.2. Integrity Testing 15.18.3. Microbiology Testing 15.19. Rest of South America Bioprocess Validation Market Forecast, By Process Component 15.19.1. Filter Element 15.19.2. Bioreactors 15.20. Rest of South America Bioprocess Validation Market Forecast, by End User 15.20.1. CDMO 15.20.2. Biotechnology 15.20.3. Pharmaceutical 15.21. South America Bioprocess Validation Market Attractiveness Analysis 15.21.1. By Test Type 15.21.2. By Process Component 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Merck KGaA (Germany) 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2 SGS S.A. (Switzerland) 16.3.3 Eurofins Scientific (Luxembourg) 16.3.4 Sartorius Stedim Biotech (France) 16.3.5 Pall Corporation (US) 16.3.6 Cobetter Filtration Equipments Co., Ltd. (China) 16.3.7 Toxikon Corporation (US) 16.3.8 DOC S.r.l. (Italy) 16.3.9 MEISSNER FILTRATION PRODUCTS, INC. (US) 16.3.10 Thermo Fisher Scientific (US) 17. Primary Key Insights

About This Report

Report ID 33430
Category Biotechnology
Published Date August 2019
No of Pages 191
Contact Us